Advanced search Help
Searching for terms: EXACT: "COVIDView: A Weekly Surveillance Summary of U.S COVID-19 Activity" in: series
Clear all search criteria
Only 2/3! You are seeing results from the Public Collection, not the complete Full Collection. Sign in to search everything (see eligibility).
-
COVIDView: A Weekly Surveillance Summary of U.S. COVID-19 Activity, Week 26 [June 27, 2020]
From the Key Updates: "Nationally, levels of influenza-like illness (ILI) and COVID-19 [coronavirus disease 2019]-like illness (CLI) activity remain lower than peaks seen in March and April but are increasing in most regions. The percentage of specimens testing positive for SARS-CoV-2 [severe acute respiratory syndrome coronavirus 2], the virus that causes COVID-19, also increased from last week. Mortality attributed to COVID-19 decreased compared to last week and is currently at the epidemic threshold but will likely increase as additional death certificates are processed."
Centers for Disease Control and Prevention (U.S.)
2020-07-02
-
COVIDView: A Weekly Surveillance Summary of U.S. COVID-19 Activity, Week 25 [June 20, 2020]
From the Document: "Nationally, levels of influenza-like illness (ILI) and COVID-19 [coronavirus disease 2019]-like illness (CLI) remain lower than peaks seen in March and April but are increasing in several regions. The percentage of specimens testing positive for SARS-CoV-2 [severe acute respiratory syndrome coronavirus 2], the virus that causes COVID-19, also increased from last week. Mortality attributed to COVID-19 decreased compared to last week but remains elevated above baseline and may increase as additional death certificates are processed."
Centers for Disease Control and Prevention (U.S.)
2020-06-20
-
COVIDView: A Weekly Surveillance Summary of U.S. COVID-19 Activity, Week 24 [June 13, 2020]
From the Document: "Nationally, levels of influenza-like illness (ILI) and COVID-19 [coronavirus disease 2019]-like illness (CLI) remain lower than peaks seen in March and April but are increasing slightly in some regions. The percentage of specimens testing positive for SARS-CoV-2 [severe acute respiratory syndrome coronavirus 2], the virus that causes COVID-19, also increased slightly from last week in some regions. Mortality attributed to COVID-19 decreased compared to last week but remains elevated above baseline and may increase as additional death certificates are processed."
Centers for Disease Control and Prevention (U.S.)
2020-06-13
-
COVIDView: A Weekly Surveillance Summary of U.S COVID-19 Activity, Week 23 [June 6, 2020]
From the Document: "Nationally, levels of influenza-like illness (ILI) and COVID-19 [coronavirus disease 2019]-like illness (CLI) continue to decline or remain stable at low levels. The percentage of specimens testing positive for SARS-CoV-2 [severe acute respiratory syndrome coronavirus 2], the virus that causes COVID-19, increased slightly from last week. Mortality attributed to COVID-19 also decreased compared to last week but remains elevated above baseline and may increase as additional death certificates are processed."
Centers for Disease Control and Prevention (U.S.)
2020-06-06
-
COVIDView: A Weekly Surveillance Summary of U.S COVID-19 Activity, Week 22 [May 30, 2020]
From the Document: "Nationally, levels of influenza-like illness (ILI) and COVID-19 [coronavirus disease 2019]-like illness (CLI) and the percentage of specimens testing positive for SARS-CoV-2 [severe acute respiratory syndrome coronavirus 2], the virus that causes COVID-19, continue to decline or remain stable at low levels. Mortality attributed to COVID-19 also decreased compared to last week but remains elevated above baseline and may increase as additional death certificates are processed."
Centers for Disease Control and Prevention (U.S.)
2020-05-30
-
COVIDView: A Weekly Surveillance Summary of U.S COVID-19 Activity, Week 21 [May 23, 2020]
From the Document: "Nationally, levels of influenza-like illness (ILI) and COVID-19 [coronavirus disease 2019]-like illness (CLI) and the percentage of specimens testing positive for SARS-CoV-2 [severe acute respiratory syndrome coronavirus 2], the virus that causes COVID-19, continue to decline or remain stable. Mortality attributed to COVID-19 also decreased compared to last week but remains elevated above baseline and may increase as additional death certificates are processed."
Centers for Disease Control and Prevention (U.S.)
2020-05-23
-
COVIDView: A Weekly Surveillance Summary of U.S COVID-19 Activity, Week 20 [May 16, 2020]
From the document: "Nationally, levels of influenza-like illness (ILI) and COVID-19 [coronavirus disease 2019]-like illness (CLI) and the percentage of specimens testing positive for SARS-CoV-2 [severe acute respiratory syndrome coronavirus 2], the virus that causes COVID-19, continue to decline. Mortality attributed to COVID-19 also decreased compared to last week but remains elevated above baseline and may increase as additional death certificates are processed."
Centers for Disease Control and Prevention (U.S.)
2020-05-16
-
COVIDView: A Weekly Surveillance Summary of U.S COVID-19 Activity, Week 19 [May 9, 2020]
From the Document: "Nationally, levels of influenza-like illness (ILI) and COVID-19 [coronavirus disease 2019]-like illness (CLI) and the percentage of specimens testing positive for SARS-CoV-2 [severe acute respiratory syndrome coronavirus 2], the virus that causes COVID-19, continue to decline. Mortality attributed to COVID-19 also decreased compared to last week but remains elevated above baseline and may increase as additional death certificates are counted."
Centers for Disease Control and Prevention (U.S.)
2020-05-09
-
COVIDView: A Weekly Surveillance Summary of U.S COVID-19 Activity, Week 18 [May 2, 2020]
From the Key Updates: "Nationally, levels of influenza-like illness (ILI) and COVID-19 [coronavirus disease 2019]-like illness (CLI) and the percentage of specimens testing positive for SARS-CoV-2 [severe acute respiratory syndrome coronavirus 2], the virus that causes COVID-19, continues to decline. Mortality attributed to COVID-19 also decreased compared to last week but remains elevated above baseline and may increase as additional death certificates are counted."
Centers for Disease Control and Prevention (U.S.)
2020-05-02
-
COVIDView: A Weekly Surveillance Summary of U.S COVID-19 Activity, Week 17 [April 25, 2020]
From the Key Updates: "Nationally, levels of influenza-like illness (ILI) declined again this week. They have been below the national baseline for two weeks but remain elevated in the northeastern and northwestern part of the country. Levels of laboratory confirmed SARS-CoV-2 [severe acute respiratory syndrome coronavirus 2] activity remained similar or decreased compared to last week. Mortality attributed to COVID-19 [coronavirus disease 2019] decreased compared to last week but remains significantly elevated and may increase as additional death certificates are counted."
Centers for Disease Control and Prevention (U.S.)
2020-04-25
-
COVIDView: A Weekly Surveillance Summary of U.S COVID-19 Activity, Week 16 [April 18, 2020]
From the Key Updates: "Levels of influenza-like illness (ILI) declined again and are below the national baseline but remain elevated in the northeast and northwest of the country. Levels of laboratory confirmed COVID-19 [coronavirus disease 2019] activity remained similar to, or decreased slightly, compared to last week. Mortality attributed to COVID-19 decreased compared to last week but remains significantly elevated and may increase as additional death certificates are counted."
Centers for Disease Control and Prevention (U.S.)
2020-04-18
-
COVIDView: A Weekly Surveillance Summary of U.S COVID-19 Activity, Week 15 [April 11, 2020]
From the Document: "This CDC [Centers for Disease Control and Prevention] report provides a weekly summary and interpretation of key indicators that have been adapted to track the COVID-19 [coronavirus disease 2019] pandemic in the United States. While influenza-like illness (ILI) declined, it is still elevated and laboratory confirmed COVID-19 activity continues to increase as do COVID-19 severity indicators (hospitalizations and deaths)."
Centers for Disease Control and Prevention (U.S.)
2020-04-11
-
COVIDView: A Weekly Surveillance Summary of U.S COVID-19 Activity, Week 14 [April 4, 2020]
From the Document: "This CDC [Centers for Disease Control and Prevention] report provides a weekly summary and interpretation of key indicators that have been adapted to track the COVID-19 [coronavirus disease 2019] pandemic in the United States. While influenza-like illness (ILI) declined, it is still elevated and laboratory confirmed COVID-19 activity continues to increase as do COVID-19 severity indicators (hospitalizations and deaths)."
Centers for Disease Control and Prevention (U.S.)
2020-04-04
-
COVIDView: A Weekly Surveillance Summary of U.S COVID-19 Activity, Week 13 [March 28, 2020]
From the Document: "This CDC [Centers for Disease Control and Prevention] report provides a weekly summary and interpretation of key indicators being adapted to track the COVID-19 [coronavirus disease 2019] pandemic in the United States. This includes information related to COVID-19 outpatient visits, emergency department visits, hospitalizations and deaths, as well as laboratory data."
Centers for Disease Control and Prevention (U.S.)
2020-03-28
-
COVIDView: A Weekly Surveillance Summary of U.S. COVID-19 Activity [series]
This is a series containing the Centers for Disease Control and Prevention (CDC) reports on "[1] Virus information: This includes COVID-19 [coronavirus disease 2019] diagnostic testing data provided by public health and clinical laboratories. [2] Outpatient and Emergency Department Visits: This is syndromic (i.e., not laboratory confirmed disease) data and will be reported as the percentage of outpatient visits for influenza-like illness (ILI) or COVID-19-like illness (CLI) nationally and in each of the 10 Health and Human Services (HHS) surveillance regions across the country. [3] Severe Disease Information: This includes information on COVID-19-associated hospitalizations and deaths."
Centers for Disease Control and Prevention (U.S.)
2020
